Stocks
Eli Lilly and Company (LLY) Debt/EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 2.02 | 1.69 | 1.48 | 1.49 | 1.79 | 1.52 | |||
| Changes by years, y/y, % | +575% | -16% | -12% | +0% | +20% | +43.0% | |||
Eli Lilly and Company. Debt/EBITDA
Eli Lilly and Company. Debt/EBITDA, changes, %
Eli Lilly and Company (LLY) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| Debt/EBITDA | 1.77 | 1.81 | 1.38 | 1.59 | 1.52 | 1.52 | ||
| Changes by years, y/y, % | +13% | +15% | +1% | +9% | -14% | |||
| Changes by quarters, q/q, % | +22% | +2% | -24% | +15% | -4% | |||
